It is a cancer drug her company discovered—one that has made her the face of a rising pharmaceutical star. When Xia founded ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...

The major donors to the Harris Victory Fund in the third and fourth quarters were former Merck CEO and Newtown resident Kenneth Frazier and Jill McDonnell of Pipersville ($500,000 each); Power ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... For example, when a CEO or CFO buys company stock, it may indicate strong confidence in the business’s future.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between ...

23, 2025, as the target decision date. Merck plans to launch Keytruda SC this year, CEO Rob Davis said at the J.P. Morgan Healthcare Conference in January. But the New Jersey pharma’s ability to ...

Amid the worst U.S.-China trade clash in modern history, Michelle Xia thinks she has something Chinese that Americans will want. It isn’t a $3 T-shirt or an electronic gadget. It is a cancer ...